Protalix BioTherapeutics, Inc.
PLX • AMEX
Protalix BioTherapeutics, Inc. is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Dror Bashan, with a market cap of $172.4M.
CEODror Bashan
Next Earnings
Upcoming earnings announcement for Protalix BioTherapeutics, Inc.
Date
Friday, May 8, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.01
Revenue Estimate
$11.5M
Earnings History
Past 12 earnings reports for Protalix BioTherapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Q4 2025 | -$0.06Est: $0.01 | -700.0% | $9.3MEst: $14.4M | -35.2% | — |
| Nov 13, 2025 | Q3 2025 | $0.03Est: $0.05 | -40.0% | $17.7MEst: $17.9M | -1.1% |  10-Q |
| Aug 14, 2025 | Q2 2025 | $0.00Est: $0.03 | -100.0% | $15.7MEst: $13.5M | +15.9% | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.05Est: $0.08 | -162.5% | $10.1MEst: $21.6M | -53.2% | 10-Q |
| Mar 17, 2025 | Q4 2024 | $0.09Est: $0.07 | +28.6% | $18.2MEst: $18.8M | -2.9% | 10-K |
| Nov 14, 2024 | Q3 2024 | $0.03Est: $0.06 | -50.0% | $18.0MEst: $16.3M | +10.4% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.03Est: $0.02 | -250.0% | $13.5MEst: $12.5M | +7.8% | 10-Q |
| May 10, 2024 | Q1 2024 | -$0.06Est: -$0.02 | -200.0% | $3.7MEst: $9.2M | -59.3% | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$0.07Est: -$0.03 | -133.3% | $10.5MEst: $5.8M | +80.8% | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.04Est: -$0.04 | 0.0% | $10.3MEst: $10.0M | +3.5% | — |
| Aug 7, 2023 | Q2 2023 | $0.21Est: -$0.04 | +625.0% | $35.1MEst: $10.2M | +243.2% | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.05 | — | $9.6M | — | 10-Q |